Nice. Already locked in 14% revenue growth this year, that number will only increase (and likely by a big number).
Management are practically begging the market to realize the value here:
"As in the past, Cogstate expects that total revenue in the 2016 financial year will exceed the amount contracted as at today’s date. For example, 63% of the A$15.2m Clinical Trials revenue for the full 2015 financial year was contracted at 30 September 2014 – see table below for more detail."
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.80 |
Change
0.015(0.84%) |
Mkt cap ! $304.7M | |||
| Open | High | Low | Value | Volume |
| $1.81 | $1.84 | $1.78 | $252.4K | 138.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2792 | $1.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.82 | 6891 | 2 |
View Market Depth
| Last trade - 16.10pm 22/07/2025 (20 minute delay) ? |
| CGS (ASX) Chart |